NYSE:ALife Sciences
Agilent (A) Launches AI Cell Imaging Software For Biopharma Research
Agilent Technologies (NYSE:A) has released an AI powered xCELLigence RTCA eSight AI software module for biopharma research.
The upgrade is designed to automate and standardize cell imaging analysis workflows, which may help reduce manual steps and variability for researchers.
The launch introduces AI driven experimental analysis tools that support high throughput drug discovery and related applications.
Agilent Technologies enters this launch with its stock at $130.69 and a mixed recent...